61811-53-8

IP (9CI)

4-Pyridazinecarboxylic acid,1,2,5,6-tetrahydro-3-methyl-5-oxo-1-phenyl-, ethyl ester

4(3H)-Quinazolinone,3-[4-[(1-cyclopentyl-4-piperidinyl)oxy]-2-fluorophenyl]-2-methyl-

4-Pyridazinecarboxylic acid,2-[(3,4-difluorophenyl)methyl]-6-(3-fluoro-4-methoxyphenyl)-2,3-dihydro-3-oxo-, methyl ester

4-Pyridazinecarboxylic acid, 6-(3,4-difluorophenyl)-2,3-dihydro-3-oxo-,methyl ester

4-Piperidinol,1-[2-(6-chloro-1H-indazol-3-yl)-1H-benzimidazol-5-yl]-4-phenyl-

4(3H)-Quinazolinone, 3-(1H-pyrazol-3-yl)-

(6-Trifluoromethyl)-7-azaindole-3-carboxylic acid

4-Pyridazinecarboxylic acid,1-(2,4-dinitrophenyl)-1,2,5,6-tetrahydro-5,6-dioxo-3-phenyl-, ethyl ester

4(3H)-Quinazolinone, 3-(1,3-benzodioxol-5-ylmethyl)-

4(3H)-Quinazolinone,3-[[[4-(dimethylamino)phenyl]methylene]amino]-2-(4-nitrophenyl)-

4-Pyridazinecarboxylic acid,6-(4-fluoro-3-methylphenyl)-2,3-dihydro-3-oxo-2-(phenylmethyl)-

4-Pyridazinecarboxylic acid,3-chloro-6-(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl-, methyl ester

4-Piperidinol,1-[2-[4-(2-benzoxazolyloxy)phenoxy]ethyl]-4-(4-chlorophenyl)-

4-Piperidinol,1-[2-[4-(1H-benzimidazol-2-yloxy)phenoxy]ethyl]-4-(4-bromophenyl)-

6-Hydroxy-2-Methyl-4-azaindole

4-Piperidinol,1-[4-(diethylamino)-2-butynyl]-3-methyl-2,6-diphenyl-4-(phenylethynyl)-

4-Pyridazinecarboxylic acid, 1,6-dihydro-6-oxo-3-phenyl-, methyl ester

4-Pyridazinecarboxylic acid,6-(3-fluoro-4-methylphenyl)-2,3-dihydro-3-oxo-, methyl ester

4(3H)-Quinazolinone,3-[4-[3-(2,5-dimethyl-1-pyrrolidinyl)propoxy]phenyl]-2-methyl-

4(3H)-Pyrimidinone,5-(3-ethenylphenyl)-3-methyl-2-[(2R)-2-[[(1-methylethyl)amino]methyl]-1-pyrrolidinyl]-6-(4-pyridinyl)-

4(3H)-Pyrimidinone,5-ethyl-2-(3-fluoro-2-hydroxyphenyl)-3-[2-(3-fluorophenyl)ethyl]-6-methyl-

4(3H)-Quinazolinone,3-[4-[(1-cyclobutyl-4-piperidinyl)oxy]-3-fluorophenyl]-2-methyl-

4-Pyridazinecarboxylic acid,2-(cyclopropylmethyl)-2,3-dihydro-6-[4-(methylthio)phenyl]-3-oxo-

4(3H)-Quinazolinone,5-fluoro-2-methyl-3-[4-[3-(1-pyrrolidinyl)butoxy]phenyl]-

4-Pyridazinecarboxylic acid,1,4,5,6-tetrahydro-5-methyl-6-(4-morpholinyl)-1-phenyl-, methyl ester

L-Aspartic acid, N-[(phenylamino)carbonyl]-, didecyl ester

4(3H)-Quinazolinone,5-hydroxy-2-methyl-3-[4-[3-(1-piperidinyl)propoxy]phenyl]-,trifluoroacetate (salt)

4-Piperidinol,1-[3-[[3-[[5-methyl-4-[5-methyl-3-(3-pyrrolidinyl)-4-isoxazolyl]-2-pyrimidinyl]amino]phenyl]amino]propyl]-

Benzoic acid, 3-(trifluoromethyl)-,(2E)-[2-(phenylmethylene)butylidene]hydrazide

4(3H)-Pyrimidinone,5-(3-bromophenyl)-2-chloro-3-methyl-6-(4-pyridinyl)-

4(3H)-Quinazolinone,5-methoxy-2-methyl-3-[4-[3-(1-pyrrolidinyl)propoxy]phenyl]-

4-Piperidinecarboxylic acid,4-amino-1-[(2R)-2-hydroxy-2-(6-methoxy-4-quinolinyl)ethyl]-, propylester

Benzenesulfonamide, 2-[[6-(2-furanyl)-4-phenyl-2-quinazolinyl]amino]-

4(3H)-Quinazolinone,3-[4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl]-5-methoxy-2-methyl-

4(3H)-Quinazolinone,3-[4-[(1-cyclopentyl-3-pyrrolidinyl)oxy]phenyl]-2-methyl-

4(3H)-Quinazolinone, 3-(2,4-dinitrophenyl)-

61811-53-8 msds

CAS No 61811-53-8 supplier

CASNo 61811-53-8 distributor

CAS # 61811-53-8 manufacturer

CAS Number 61811-53-8 safety

CAS RN 61811-53-8 wholesale

2026-10-14 IP (9CI),CAS No.61811-53-8,Formula:. Find Related Products for Bulk Production or Scientific Research